Kulinskiĭ V I, Kolesnichenko L S, Kovtun V Iu, Sotnikova G V
Biomed Khim. 2003 Sep-Oct;49(5):424-33.
Methodic approaches for the purposeful changes of glutathione concentration in the brain and liver by administration of glutathione depletors and prodrugs have been modified. Two different depletors (diethylmaleate and buthionine sulfoximine) cause considerable increase of tolerance to the complete global cerebral ischemia and hypothermia development which correlate closely with the decrease of GSH concentration. Five GSH prodrugs (GSH esters and oxothiazolidine carboxilate) and GSH itself usually decrease slightly body temperature but do not influence tolerance to ischemia in the most of series. The increase of tolerance to the complete global cerebral ischemia is connected not with GSH accumulation, but with its decrease. Evidently one of the two opposite GSH effects, sensitizing or protecting one, can predominate in different forms of cerebral ischemia.
通过给予谷胱甘肽消耗剂和前药来有目的地改变大脑和肝脏中谷胱甘肽浓度的方法已被改进。两种不同的消耗剂(马来酸二乙酯和丁硫氨酸亚砜胺)可使对完全性全脑缺血和体温过低的耐受性显著增加,这与谷胱甘肽浓度的降低密切相关。五种谷胱甘肽前药(谷胱甘肽酯和氧代噻唑烷羧酸盐)以及谷胱甘肽本身通常会使体温略有下降,但在大多数实验系列中对缺血耐受性没有影响。对完全性全脑缺血耐受性的增加并非与谷胱甘肽的积累有关,而是与其减少有关。显然,在不同形式的脑缺血中,谷胱甘肽两种相反作用(致敏或保护作用)之一可能占主导。